4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-061319
Chief Scientific Officer sold 11,200 shares at an average $33.71 ($377,561)
- Chief Scientific Officer acquired 11,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-19 | Exercise or conversion : show line 1 in the form | +3,800 | $6.55 | $24,890 | 73,160 | D |
| 2021-10-19 | Sale : show line 2 in the form | −300 | $32.91 | $9,873 | 72,860 | D |
| 2021-10-19 | Sale : show line 3 in the form | −3,500 | $33.76 | $118,160 | 69,360 | D |
| 2021-10-20 | Exercise or conversion : show line 4 in the form | +3,700 | $6.55 | $24,235 | 73,060 | D |
| 2021-10-20 | Sale : show line 5 in the form | −3,700 | $33.71 | $124,727 | 69,360 | D |
| 2021-10-21 | Exercise or conversion : show line 6 in the form | +3,700 | $6.55 | $24,235 | 73,060 | D |
| 2021-10-21 | Sale : show line 7 in the form | −3,700 | $33.73 | $124,801 | 69,360 | D |
| Open-market sales · 11,200 sh · avg $33.71 · $377,561 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-19 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,800 | 296,200 | D |
| 2021-10-20 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −3,700 | 292,500 | D |
| 2021-10-21 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −3,700 | 288,800 | D |
Loading xslF345X03/doc4.xml…